1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Registered Office :
Address : 208,Okhla Industrial Estate,Phase - 111 New Delhi,Delhi-110020 .
Phone : 011-46846700
Email :  contact@mankindpharma.com
URL : www.mankindpharma.com
Industry : Pharmaceuticals & Drugs
Listing : BSE,NSE